
Assistant Researcher
M_MED-ZSFG-PULM
+1 628 206-8101
My research focusses on the causative agent of tuberculosis, Mycobacterium tuberculosis: I apply a combination of wet work and bioinformatics to investigate genomic and transcriptional associates of drug resistance, clinical outcomes, and patient infectiousness. See www.SemiQuant.com for more information.
Publications
stilPCR increases the effective sequencing length of Illumina targeted next-generation sequencing.
Research Square
selSeq: A method for the enrichment of non-polyadenylated RNAs including enhancer and long non-coding RNAs for sequencing.
Research Square
Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis.
D_Cell and Tissue Biology
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis.
P_Pharmaceutical Chemistry
A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic.
Public health
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study.
M_Epidemiology & Biostatistics
Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?
The American journal of tropical medicine and hygiene